Sarah H Johnson Selected Research

Mesothelioma

1/2023	Dynamics and survival associations of T cell receptor clusters in patients with pleural mesothelioma treated with immunotherapy.
1/2019	Neoantigenic Potential of Complex Chromosomal Rearrangements in Mesothelioma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sarah H Johnson Research Topics

Disease

24	Neoplasms (Cancer) 01/2023 - 01/2011
6	Prostatic Neoplasms (Prostate Cancer) 01/2019 - 10/2012
2	Mesothelioma 01/2023 - 01/2019
2	Neoplasm Metastasis (Metastasis) 01/2020 - 12/2014
2	Adenocarcinoma of Lung 11/2016 - 03/2015
1	Endometrial Neoplasms (Endometrial Cancer) 01/2023
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 05/2021
1	Breast Neoplasms (Breast Cancer) 01/2020
1	Glioblastoma (Glioblastoma Multiforme) 01/2020
1	Glioma (Gliomas) 01/2020
1	Malignant Mesothelioma 01/2019
1	Lung Neoplasms (Lung Cancer) 01/2019
1	Rhabdomyosarcoma 01/2019
1	Alveolar Rhabdomyosarcoma 01/2019
1	Neuroendocrine Carcinoma 01/2019
1	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 01/2019
1	Carcinogenesis 12/2018
1	Rare Diseases (Rare Disease) 01/2017
1	Lymphangioleiomyomatosis (Lymphangiomyomatosis) 01/2017
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2017
1	Ovarian Neoplasms (Ovarian Cancer) 01/2016
1	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 01/2016
1	Genetic Translocation (Chromosomal Translocation) 11/2013
1	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 11/2013
1	Hematologic Neoplasms (Hematological Malignancy) 11/2013
1	Disease Progression 06/2013
1	Lymphoma (Lymphomas) 01/2011

Drug/Important Bio-Agent (IBA)

8	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 10/2012
6	Proteins (Proteins, Gene)FDA Link 05/2021 - 11/2013
4	RNA (Ribonucleic Acid)IBA 01/2023 - 11/2013
2	Tyrosine Kinase InhibitorsIBA 01/2022 - 01/2019
2	Hormones (Hormone)IBA 01/2020 - 01/2015
2	Biomarkers (Surrogate Marker)IBA 01/2019 - 10/2012
2	Anaplastic Lymphoma KinaseIBA 11/2016 - 11/2013
1	Azacitidine (5 Azacytidine)FDA Link 01/2023
1	Decitabine FDA Link 01/2023
1	IpilimumabIBA 01/2023
1	Complementarity Determining Regions (Complementarity Determining Region)IBA 01/2023
1	ChromatinIBA 01/2023
1	NivolumabIBA 01/2023
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2023
1	Immune Checkpoint InhibitorsIBA 01/2023
1	Imatinib Mesylate (Gleevec)FDA Link 09/2022
1	VaccinesIBA 01/2020
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2020
1	AntigensIBA 01/2020
1	SynaptophysinIBA 01/2019
1	AsbestosIBA 01/2019
1	CarcinogensIBA 01/2019
1	ChromograninsIBA 01/2019
1	DesminIBA 01/2019
1	Transcription Factors (Transcription Factor)IBA 01/2019
1	MyogeninIBA 01/2019
1	Mechanistic Target of Rapamycin Complex 1IBA 12/2018
1	Coloring Agents (Dyes)IBA 01/2017
1	Hematoxylin (Haematoxylon)IBA 01/2017
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2017
1	Eosine Yellowish-(YS) (Eosin)IBA 01/2017
1	Cell-Free Nucleic AcidsIBA 01/2016
1	AndrogensIBA 01/2015
1	PoisonsIBA 01/2015
1	Androgen Receptors (Androgen Receptor)IBA 01/2015
1	Fluconazole (Zonal)FDA LinkGeneric 06/2014
1	TNF Receptor-Associated Factor 1IBA 11/2013
1	GP 4 (GP4)IBA 06/2013
1	MicroRNAs (MicroRNA)IBA 01/2011

Therapy/Procedure

9	Therapeutics 01/2023 - 01/2015
6	Lasers (Laser) 01/2017 - 10/2012
2	Prostatectomy (Retropubic Prostatectomy) 11/2017 - 02/2016
1	Immunotherapy 01/2023
1	Drug Therapy (Chemotherapy) 05/2021
1	Precision Medicine 01/2020